These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2565161)

  • 1. Positive inotropic/vasodilator agents.
    Colucci WS
    Cardiol Clin; 1989 Feb; 7(1):131-44. PubMed ID: 2565161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some new positive inotropic agents.
    Andersson KE
    Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New positive inotropic drugs in acute and chronic heart failure].
    Follath F
    Schweiz Rundsch Med Prax; 1992 May; 81(21):704-7. PubMed ID: 1351309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Positive inotropic agents. Generalities and classification].
    Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
    Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: therapeutic concepts of congestive heart failure.
    Haustein KO
    Int J Clin Pharmacol Ther Toxicol; 1990 Jul; 28(7):273-81. PubMed ID: 1974888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of chronic heart failure with positive inotropic agents].
    Lechat P
    Therapie; 1989; 44(6):437-45. PubMed ID: 2576155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inodilator therapy for heart failure. Early, late, or not at all?
    Remme WJ
    Circulation; 1993 May; 87(5 Suppl):IV97-107. PubMed ID: 8097971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination therapy with PDE III inhibitor for heart failure].
    Watanabe H; Kajimoto K; Kawana M
    Nihon Rinsho; 2007 May; 65 Suppl 5():134-9. PubMed ID: 17571377
    [No Abstract]   [Full Text] [Related]  

  • 11. New cardiac drugs.
    Kikura M; Levy JH
    Int Anesthesiol Clin; 1995; 33(1):21-37. PubMed ID: 7635556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The differential therapy of chronic heart failure].
    Schüren KP
    Dtsch Med Wochenschr; 1990 Aug; 115(35):1319-24. PubMed ID: 1975236
    [No Abstract]   [Full Text] [Related]  

  • 13. New inotropic drugs for treatment of congestive heart failure.
    Schwertz DW; Piano MR
    Cardiovasc Nurs; 1990; 26(2):7-12; discussion 12. PubMed ID: 1969769
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessing the treatment of congestive heart failure: inotropic agents and calcium channel blockers.
    Hilleman DE
    Pharmacotherapy; 1993; 13(5 Pt 2):88S-93S. PubMed ID: 7901842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel approach to the development of positive inotropic agents for chronic heart failure.
    Packer M
    J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S52-6. PubMed ID: 8907131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Jan; 314(5):290-9. PubMed ID: 2867470
    [No Abstract]   [Full Text] [Related]  

  • 17. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
    Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L
    Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706
    [No Abstract]   [Full Text] [Related]  

  • 18. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
    Weber KT; Janicki JS; Jain MC
    J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with beta-adrenergic receptor antagonists and phosphodiesterase inhibitors for chronic heart failure.
    Van Tassell BW; Radwanski P; Movsesian M; Munger MA
    Pharmacotherapy; 2008 Dec; 28(12):1523-30. PubMed ID: 19025433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P; Parry G; Dark JH; Macgowan GA
    J Heart Lung Transplant; 2009 Jul; 28(7):676-82. PubMed ID: 19560695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.